Patient safety is at the heart of every successful pharmaceutical product. Glaers Pharmacovigilance (PV) Consulting Services help companies establish compliant, scalable, and inspection-ready pharmacovigilance systems that meet global regulatory requirements.
From clinical development through post-marketing surveillance, our experienced pharmacovigilance consultants provide strategic guidance, operational support, regulatory compliance, and risk management solutions aligned with FDA, EMA, MHRA, PMDA, Health Canada, TGA, CDSCO and other international health authorities.
Whether you require complete PV outsourcing, process optimization, local QPPV support, software implementation, or regulatory inspections preparation, we deliver tailored solutions that ensure continuous patient safety and regulatory compliance.
Our consultants possess extensive experience across global regulatory frameworks, helping organizations establish compliant and scalable pharmacovigilance operations.
Our quality-driven approach ensures your pharmacovigilance systems remain audit-ready at all times.
We provide end-to-end pharmacovigilance consulting across to ensure complete regulatory compliance.
Capture and process safety information from multiple reporting
channels.
Supported sources:
Efficient adverse event processing throughout the product lifecycle.
Preparation of global safety reports compliant with international regulations.
Prepare your organization for regulatory inspections.
Establish inspection-ready pharmacovigilance infrastructure.
Our solution is designed to serve across lifescience industry where consumer safety and regulatory compliances are required.